Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Sonnet BioTherapeutics Holdings Inc’s current trading price is 8.78% away from its 52-week high, while its distance from the 52-week low is 909.26%. The stock’s price range during this period has varied between $1.08 and $10.02. The company, active in the Healthcare sector, saw a trading volume of around 33.18 million for the day, considerably higher average daily volume of 2.87 million observed over the last three months.
The current stock price for Sonnet BioTherapeutics Holdings Inc (SONN) is $10.9. The stock experienced a significant increase during the last trading session, reaching $20.0 after opening at $10.9. It dipped to a low of $20.0 before ultimately closing at $5.17.
Sonnet BioTherapeutics Holdings Inc’s stock market performance has been consistent. The 1-year high for the company’s stock was recorded at $10.02 on 07/14/25, with the lowest value being $1.08 on 05/27/25.
How Financial Performance Impacts Market Capitalization
Sonnet BioTherapeutics Holdings Inc (SONN) has experienced a quarterly rise of 779.03% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 34.51M and boasts a workforce of 13 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.64, with a change in price of +10.10. Similarly, Sonnet BioTherapeutics Holdings Inc recorded 2,084,801 in trading volume during the last 100 days, posting a change of +660.13%.
How SONN’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for SONN stands at 0.14. Similarly, the long-term debt-to-equity ratio is also 0.00.
SONN Stock Stochastic Average
As of today, the raw stochastic average of Sonnet BioTherapeutics Holdings Inc over the past 50 days is 59.30%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 59.26%. Additionally, the Stochastic %K and %D values for the company were 75.87% and 77.17%, respectively, over the past 20 days.
SONN Stock Price Performance Analysis
Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. The metric has seen a significant gain of 62.18% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 603.23%. Over the past 30 days, the price of SONN has fallen by 831.54%. And in the last five days, it has surged by 130.44%.
